Oncology Institute Inc

General ticker "TOI" information:

  • Sector: Health Care
  • Industry: Health Care Providers & Services
  • Capitalization: $14.6M

Oncology Institute Inc does not follow the US Stock Market performance with the rate: -41.0%.

Estimated limits based on current volatility of 7.9%: low 0.18$, high 0.22$

Factors to consider:

  • Current price 85.7% below estimated low
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.43$, 3.51$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.30$, 3.17$]

Financial Metrics affecting the TOI estimates:

  • Negative: Non-GAAP EPS, $ of -0.69 <= 0.10
  • Negative: Operating profit margin, % of -19.19 <= 1.03
  • Negative: Operating cash flow per share per price, % of -24.26 <= 2.35
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of 0.28 <= 1.08

Similar symbols

Short-term TOI quotes

Long-term TOI plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $203.00MM $252.48MM $324.24MM
Operating Expenses $248.86MM $324.49MM $401.26MM
Operating Income $-45.86MM $-72.01MM $-77.02MM
Non-Operating Income $34.26MM $73.91MM $-6.09MM
Interest Expense $0.32MM $4.08MM $6.78MM
Income(Loss) $-11.60MM $1.90MM $-83.10MM
Taxes $-0.67MM $0.25MM $-0.04MM
Profit(Loss) $-10.93MM $1.66MM $-83.07MM
Stockholders Equity $104.16MM $123.17MM $57.02MM
Assets $203.44MM $261.67MM $209.24MM
Operating Cash Flow $-32.68MM $-61.76MM $-36.31MM
Capital expenditure $3.05MM $5.53MM $4.57MM
Investing Cash Flow $-12.15MM $-131.61MM $62.64MM
Financing Cash Flow $154.01MM $92.21MM $-6.85MM
Earnings Per Share* $-0.16 $0.02 $-0.92

* EPS are Split Adjusted, recent splits may be reflected with a delay.